Leader Biomedical introduces Hyalosyn™ Gel

Amsterdam | 28 May 2019 | Leader Biomedical introduces Hyalosyn™ Gel, a 1% sodium hyaluronate viscoelastic sterile solution, manufactured by synthetic fermentation, with no microbiological residues. Hyalosyn™ Gel comes in a re-filled syringe for easy injection into synovial joints. Treatment with HA is clinically proven for osteoarthritis for over 10 years to facilitate improved joint mobility and reduce pain caused by osteoarthritis, or at first signs of movement limitations and joint pain.

Benefits of Hyalosyn™ Gel:

• Manufactured by synthetic fermentation
• No microbiological residues
• Suitable for intra-articular injection into all synovial joints
• Sterile solution in pre-filled syringe with cap
• Easy injection